Home Structure Partners Klaus F. Wagner
Discipline: Anaesthesiology
Specialities:
In NESA as: Partner
Since: 2005
Institution: University Clinic Schleswig-Holstein
Position: Senior physician
City: Lübeck
Country: Germany
E-Mail: wagner@anaesthesie.uni-luebeck.de
Postal address:University Clinic Schleswig-Holstein Campus Lübeck Clinic of Anesthesiology Ratzeburger Allee 160 D-23538 Lübeck
Phone number: +49-451-500-4057
Website: http://www.physio.uni-luebeck.de/klaus_wagner/start_kl.htm
Education: Oktober 1977 - Juli 1982 Medizinstudium an der Universität Düsseldorf Oktober 1982 - Okt. 1985 Medizinstudium an der Universität Lübeck Oktober 1984 - Feb. 1985 Auslandssemester an der Christchurch Medical School, University of Otago, Christchurch, Neuseeland Februar 1985 - Sept. 1985 Auslandssemester an der University of Melbourne, Melbourne, Australien 25.11.1985 Drittes Staatsexamen, Approbation
CV: Download
American Society of Anesthesiologists (ASA, since 2003) Deutsche Physiologische Gesellschaft (DPG, since 2000) European Society of Anaesthesiologists (ESA, since 1998) Gesellschaft für Informatik (GI, since 1995) Deutsche Gesellschaft für Anästhesiologie und Intensivmedizin (DGAI, since 1994) Berufsverband Deutscher Anästhesisten (BDA, since 1994) Deutsche Gesellschaft für medizinische Informatik, Biometrie und Epidemiologie (GMDS, since 1993)
Iber Th., Weiss M., Wagner K.F., Leidinger W., Sehn N., Garling A., Klöss Th. (2006) Grundlagen der anästhesiologischen Personalbedarfsplanung im DRG-Zeitalter. Anästh Intensivmed 47:S25-S36 Depping R., Kawakami K., Ocker H., Wagner J.M., Heringlake M., Noetzold A., Sievers H.-H., Wagner K.F.(2005) Expression of the Erythropoietin Receptor in Human Heart: J Thorac Cardiov Sur 2005;130:877-78, IF 3.319 Jelkmann W., Wagner K.F. (2004) Beneficial and ominous aspects of the pleiotropic action of erythropoietin Ann Hematol, 83, 673-86, IF 1,241. Briest W., Homagk L., Baba H.A., Deten A., Raßler B., Tannapfel A., Wagner K.F., Wenger R.H., Zimmer H.-G. (2004) Cardiac remodeling in erythropoietin transgenic mice. Cell Physiol Biochem 14, 277-84, IF 2,480. Wagner K.F., Hellberg A.-K., Balenger S., Dodd-O J., Johns R.A., Li D.(2004) Hypoxia-Induced Mitogenic Factor has anti-apoptotic action and is up-regulated in the developing lung at late gestation: co-expression with HIF-2 but not HIF-1. Am J Resp Cell Mol Biol 169, 829-35, IF 4.170 Depping R., Hägele S., Wagner K.F., Wiesner R., Camenisch G., Wenger R.H., Katschinski D.M. (2004) A Dominant-Negative Isoform of Hypoxia-Inducible Factor-1alpha]Is Specifically Expressed in Human Testis. Biol Reprod 71, 331-39. IF 3,646 Hasegawa J., Wagner K.F. (Co-Erstautorschaft Hasegawa u. Wagner), Karp D., Li D., Shibata J., Heringlake M., Bahlmann L., Depping R., Fandrey J., Schmucker P., Uhlig S. (2004) Altered pulmonary vascular reactivity in mice with excessive erythrocytosis. Am J Resp Crit Care, 169(7): 829-35. IF 6.567 Shibata J., Hasegawa J., Siemens H.J., Wolber E., Dibbelt L., Li D., Katschinski D.M., Fandrey J., Jelkmann W., Gassmann G., Wenger R.H., Wagner K.F. (2003). Hemostasis and coagulation at a hematocrit of 0.85: functional consequences of erythrocytosis. Blood, 101:4416-4422, IF 9,273 Bahlmann L., Klaus S., Heringlake M., Baumeier W., Schmucker P., Wagner K.F. (2002) Rescue of a patient out of a grain container: the quicksand effect of grain. Resuscitation 53:1 101-4, IF=1.760 Ruschitzka F.T., Wenger R.H., Stallmach T., Quaschning T., de Wit C., Wagner K.F., Labugger R., Kelm M., Noll G., Rülicke T., Shaw S., Lindberg R.L.P., Rodenwaldt B., Lutz H., Bauer C., Lüscher T.F. and Gassmann M. (2000) Nitric oxide maintains cardiovascular function and determines survival in polyglobulic mice overexpressing erythropoietin. Proc. Natl. Acad. Sci. USA 21, 11609-11613. IF=10.789
Publication list: Download
Structure Partners Klaus F. Wagner 
